Comments
Roche chairman says Illumina bid off the table: paper
06.01.2013. | ZURICH (Reuters) - Swiss pharmaceutical group Roche is no longer considering a bid for U.S. gene-sequencing company Illumina , Chairman Franz Humer was quoted as saying in a newspaper interview on Sunday....
